Caley Castelein - Net Worth and Insider Trading

Caley Castelein Net Worth

The estimated net worth of Caley Castelein is at least $22 Million dollars as of 2024-12-25. Caley Castelein is the Director of Tourmaline Bio Inc and owns about 974,558 shares of Tourmaline Bio Inc (TRML) stock worth over $21 Million. Caley Castelein is the Director of Aadi Bioscience Inc and owns about 279,692 shares of Aadi Bioscience Inc (AADI) stock worth over $839,076. Caley Castelein is also the Director of ViewRay Inc and owns about 99,047 shares of ViewRay Inc (VRAYQ) stock worth over $1. Details can be seen in Caley Castelein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caley Castelein has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Caley Castelein

To

Caley Castelein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caley Castelein owns 5 companies in total, including Aerpio Pharmaceuticals Inc (ARPO) , ViewRay Inc (VRAYQ) , and Neos Therapeutics Inc (NEOS) among others .

Click here to see the complete history of Caley Castelein’s form 4 insider trades.

Insider Ownership Summary of Caley Castelein

Ticker Comapny Transaction Date Type of Owner
ARPO Aerpio Pharmaceuticals Inc 2020-06-24 director
VRAYQ ViewRay Inc 2023-07-19 director
NEOS Neos Therapeutics Inc 2015-07-28 10 percent owner
LIMIT LIMIT 2021-08-26 director
LIMIT LIMIT 2023-10-19 director

Caley Castelein Latest Holdings Summary

Caley Castelein currently owns a total of 3 stocks. Among these stocks, Caley Castelein owns 974,558 shares of Tourmaline Bio Inc (TRML) as of October 27, 2023, with a value of $21 Million and a weighting of 96.13%. Caley Castelein owns 279,692 shares of Aadi Bioscience Inc (AADI) as of August 26, 2021, with a value of $839,076 and a weighting of 3.87%. Caley Castelein also owns 99,047 shares of ViewRay Inc (VRAYQ) as of July 19, 2023, with a value of $1 and a weighting of 0%.

Latest Holdings of Caley Castelein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRML Tourmaline Bio Inc 2023-10-27 974,558 21.40 20,850,668
AADI Aadi Bioscience Inc 2021-08-26 279,692 3.00 839,076
VRAYQ ViewRay Inc 2023-07-19 99,047 0.00 1

Holding Weightings of Caley Castelein


Caley Castelein Form 4 Trading Tracker

According to the SEC Form 4 filings, Caley Castelein has made a total of 1 transactions in Tourmaline Bio Inc (TRML) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tourmaline Bio Inc is the acquisition of 20,000 shares on October 27, 2023, which cost Caley Castelein around $280,600.

According to the SEC Form 4 filings, Caley Castelein has made a total of 1 transactions in Aadi Bioscience Inc (AADI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aadi Bioscience Inc is the acquisition of 259,998 shares on August 26, 2021, which cost Caley Castelein around $3 Million.

According to the SEC Form 4 filings, Caley Castelein has made a total of 2 transactions in ViewRay Inc (VRAYQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in ViewRay Inc is the sale of 2,345,030 shares on July 19, 2023, which brought Caley Castelein around $140,702.

Insider Trading History of Caley Castelein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caley Castelein Trading Performance

GuruFocus tracks the stock performance after each of Caley Castelein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caley Castelein is 103.96%. GuruFocus also compares Caley Castelein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caley Castelein within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Caley Castelein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Caley Castelein

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.3 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 20.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Caley Castelein Ownership Network

Ownership Network List of Caley Castelein

No Data

Ownership Network Relation of Caley Castelein

Insider Network Chart

Caley Castelein Owned Company Details

What does Aerpio Pharmaceuticals Inc do?

Who are the key executives at Aerpio Pharmaceuticals Inc?

Caley Castelein is the director of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .

Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aerpio Pharmaceuticals Inc Insider Transactions

No Available Data

Caley Castelein Mailing Address

Above is the net worth, insider trading, and ownership report for Caley Castelein. You might contact Caley Castelein via mailing address: Thom. Weisel Healthcare Ventures, One Montgomery Street, San Francisco Ca 94104.

Discussions on Caley Castelein

No discussions yet.